Gold, Silver and Platinum in Medicine – Columns

In the wake of the pandemic, gold, platinum and silver prices rose sharply. These precious metals are playing an increasingly important role in medicine.

Investors rushed to precious metals as a safe haven. But in addition to the financial protective function, silver is used to detect the Covid-19 virus. Silver and gold nanoparticles are used in serological tests, a type of blood test. Silver is also used in some masks.

There is a recognizable trend in the healthcare sector to use more and more precious metals. This is all the more true as the population is aging. In the United States, for example, health spending is expected to grow by around $ 6 trillion annually. Gold and platinum are already used today in the fight against certain types of cancer. Platinum slows cell division and has long been used in chemotherapy treatments.

Silver prevents microbial infections and was an important tool before antibiotics existed, known for thousands of years. Gold nanoparticles are being researched for testing and treating AIDS. Gold also has anti-inflammatory properties. Gold, silver, and platinum also offer benefits in medical devices. Platinum is used, for example, in pacemakers.

Around three to five percent of the entire precious metals market goes into the health sector, and the trend is rising. However, if you are interested in these metals as an investor, you should look at the companies behind them such as Fury Gold Mines or Aguila American Gold.

Fury Gold Mines – – Develops and develops multi-million ounce gold projects in Canada. The company is active in three productive mining areas. Aguila American Gold – – brings the Wusa Gold-Silver Project in Oregon back to life. The property makes up around 70,000 hectares of promising gold land.

Current company information and press releases from Fury Gold Mines (- -).

In accordance with Section 34 of the WpHG, I would like to point out that partners, authors and employees can hold shares in the companies addressed and that there is thus a possible conflict of interest. No guarantee for the translation into German. Only the English version of these messages applies.

Disclaimer: The information provided does not represent any form of recommendation or advice. Express reference is made to the risks in securities trading. No liability can be assumed for damage caused by using this blog. I would like to point out that stocks and especially warrant investments are generally associated with risk. The total loss of the capital employed cannot be ruled out. All information and sources are carefully researched. However, no guarantee is given for the correctness of any content. Despite the greatest care, I expressly reserve the right to make errors, particularly with regard to figures and rates. The information it contains comes from sources that are believed to be reliable, but in no way claims to be correct or complete. Due to court judgments, the content of linked external pages is jointly responsible (e.g. Hamburg Regional Court, in the judgment of May 12, 1998 – 312 O 85/98), as long as no express distancing is made. Despite careful control of the content, I assume no liability for the content of linked external sites. The respective operators are solely responsible for their content. The disclaimer of Swiss Resource AG also applies:

PERSONAL-FINANCIAL.COM publishes analyzes, columns and news from various sources in this section.
PERSONAL-FINANCIAL.COM AG is not responsible for content that is recognizable by third parties in the “News” area
This website has been discontinued and does not adopt it as its own. These contents are in particular through
a corresponding “from” mark below the article heading and / or through the link
“To read the full article, please click here.” responsible for
this content is solely the named third party.


Related Articles

Back to top button